Lexeo Therapeutics Inc. C...

3.46
-0.64 (-15.61%)
At close: Mar 31, 2025, 3:59 PM
3.43
-0.92%
After-hours: Mar 31, 2025, 07:59 PM EDT

Lexeo Therapeutics Common Stock Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20
Cash & Equivalents 35.01M 121.47M 77.33M 135.86M 29.37M
Short-Term Investments 86.5M n/a n/a n/a n/a
Long-Term Investments 7.01M n/a 3.25M n/a n/a
Other Long-Term Assets 3.25M 3.25M 3.25M 2K 2.5K
Receivables n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a
Other Current Assets 4.6M 2.83M 2.71M 824K 33.57K
Total Current Assets 126.12M 124.29M 80.05M 136.68M 29.41M
Property-Plant & Equipment 10.56M 12.26M 13.78M 174K n/a
Goodwill & Intangibles n/a n/a -7.49M n/a n/a
Total Long-Term Assets 20.82M 15.51M 17.03M 176K 2.5K
Total Assets 146.94M 139.81M 97.08M 136.86M 29.41M
Account Payables 6.42M 3.79M 2.68M 3.06M 44.32K
Deferred Revenue n/a n/a 8.6M 46K 140.38K
Short-Term Debt 2.67M 2.6M 2.83M n/a n/a
Other Current Liabilities 13.76M 10.68M 8.33M 3.81M 474.71K
Total Current Liabilities 22.85M 17.24M 14.35M 7.45M 697.72K
Long-Term Debt 7.25M 9.03M 10.65M n/a n/a
Other Long-Term Liabilities n/a n/a 185.03M 185.01M 34.25M
Total Long-Term Liabilities 7.25M 9.03M 195.68M 185.01M 34.25M
Total Liabilities 30.1M 26.27M 210.03M 192.46M 34.95M
Total Debt 9.92M 11.64M 13.48M n/a 3.01M
Common Stock 3K 3K 2K 2K 1.6K
Retained Earnings -280.17M -181.84M -115.45M -56.17M -5.55M
Comprehensive Income -103K n/a -185.03M -185.01M -31.24M
Shareholders Equity 116.84M 113.53M -112.95M -55.6M -5.54M
Total Investments 93.52M 3.25M 3.25M n/a n/a